Grade Group 1 Core Volume at Time of Biopsy Is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy
Alex Leonard(The University of Texas MD Anderson Cancer Center), Justin R. Gregg(The University of Texas MD Anderson Cancer Center), John Papadopoulos(The University of Texas MD Anderson Cancer Center), John W. Davis(Barnes-Jewish Hospital), Patricia Troncoso(The University of Texas MD Anderson Cancer Center), Louis L. Pisters(The University of Texas MD Anderson Cancer Center), R. García(The University of Texas MD Anderson Cancer Center), Curtis A. Pettaway(The University of Texas MD Anderson Cancer Center), Carrie R. Daniel(The University of Texas MD Anderson Cancer Center), Brian F. Chapin(The University of Texas MD Anderson Cancer Center), Jiansong Chen(The University of Texas MD Anderson Cancer Center), Lisly Chéry(The University of Texas MD Anderson Cancer Center), Peng Wei(Creighton University)
Cited by 3
Related Papers
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
|The Lancet Oncology|2018|658
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592